Displaying drugs 2351 - 2375 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Omidenepag isopropyl | 520.61 C26H28N6O4S |  | An agonist of the prostaglandin EP2 receptor indicated for the reduction of elevated intraocular pressure. | Antiglaucoma Agents / Hypotensive Agents / Ophthalmic Solutions / Ophthalmics / Prodrugs / Pyrazoles / Pyridines / Receptors, Prostaglandin E, EP2 Subtype, agonists / Sulfonamides |
| Beclomethasone dipropionate | 521.042 C28H37ClO7 |  | An inhaled corticosteroid used as maintenance treatment in the prophylaxis of asthma attacks. | Corticosteroids Acting Locally / Corticosteroids, Potent (Group III) / Glucocorticoids |
| Mometasone furoate | 521.429 C27H30Cl2O6 |  | A corticosteroid used to treat asthma, allergic rhinitis, nasal congestion, nasal polyps, dermatitis, and pruritus. | Corticosteroids, Potent (Group III) / Glucocorticoids |
| Ticagrelor | 522.568 C23H28F2N6O4S |  | A P2Y12 platelet inhibitor used in patients with a history of myocardial infarction or with acute coronary syndrome (ACS) to prevent future myocardial infarction, stroke and cardiovascular death. | Platelet Aggregation Inhibitors Excl. Heparin |
| Diacetyl benzoyl lathyrol | 522.638 C31H38O7 |  | Diacetyl benzoyl lathyrol is an active ingredient in whitening creams. It is also reported to be a skin conditioning agent. | Not Annotated |
| Fedratinib | 524.678 C27H36N6O3S |  | Fedratinib is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.[L8090,L47016] | Janus Kinase Inhibitor / Protein Kinase Inhibitors |
| Selpercatinib | 525.613 C29H31N7O3 |  | A RET receptor tyrosine kinase inhibitor for the treatment of RET-driven non-small cell lung cancer, medullary thyroid cancer, and thyroid cancer in appropriate patient populations. | Kinase Inhibitor |
| Cefotiam | 525.628 C18H23N9O4S3 |  | A cephalosporin antibiotic used to treat a variety of bacterial infections. | Anti-Bacterial Agents / Second-Generation Cephalosporins |
| Sodium aurotiosulfate | 526.2 AuH4Na3O8S4 |  | Not Annotated | Gold Preparations |
| Oteseconazole | 527.403 C23H16F7N5O2 |  | An azole antifungal used to prevent recurrent vulvovaginal candidiasis in females who are not of reproductive potential. | Triazole and tetrazole derivatives |
| Daunorubicin | 527.5199 C27H29NO10 |  | An anthracycline aminoglycoside used to induce remission of nonlymphocytic leukemia and acute lymphocytic leukemia. | Anthracyclines and Related Substances |
| Rolitetracycline | 527.5662 C27H33N3O8 |  | A broad-spectrum tetracycline antibiotic used in cases needing high concentrations or when oral administration is impractical. | Tetracyclines |
| Gliquidone | 527.632 C27H33N3O6S |  | A sulfonylurea drug used in the management of diabetes mellitus type 2. | Sulfonylureas |
| Dutasteride | 528.5297 C27H30F6N2O2 |  | An antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) in adult males by inhibiting 5-alpha reductase. | Adrenergic alpha-Antagonists |
| Lumefantrine | 528.94 C30H32Cl3NO |  | An antimalarial agent used in combination with artemether for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum. | Antiprotozoals |
| Sofosbuvir | 529.458 C22H29FN3O9P |  | A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. | Antivirals for treatment of HCV infections |
| Nilotinib | 529.5158 C28H22F3N7O |  | A kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib. | Protein Kinase Inhibitors |
| Rocuronium | 529.7742 C32H53N2O4 |  | A vecuronium analog used to facilitate tracheal intubation and to relax skeletal muscles during surgery. | Agents producing tachycardia |
| Bortezomib D-mannitol | 530.39 C25H35BN4O8 |  | Not Annotated | Proteasome Inhibitors |
| Bosutinib | 530.446 C26H29Cl2N5O3 |  | An antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. | Bcr-Abl Tyrosine Kinase Inhibitors / Protein Kinase Inhibitors |
| Glycerol phenylbutyrate | 530.6512 C33H38O6 |  | A nitrogen-binding agent used to manage patients with urea cycle disorders who cannot be sufficiently managed amino acid supplementation and/or dietary restrictions. | Various Alimentary Tract and Metabolism Products |
| alpha-Tocopherol succinate | 530.79 C33H54O5 |  | A form of vitamin E used to treat and prevent vitamin deficiencies. | Antioxidants / Tocopherols / Vitamins |
| Cobimetinib | 531.318 C21H21F3IN3O2 |  | An antineoplastic agent and selective inhibitor of the mitogen-activated extracellular kinase (MEK) pathway used to treat unresectable or metastatic melanoma. | Mitogen-activated protein kinase (MEK) inhibitors / Protein Kinase Inhibitors |
| Ketoconazole | 531.431 C26H28Cl2N4O4 |  | A broad spectrum antifungal used to treat seborrheic dermatitis and fungal skin infections. | Anticorticosteroids / Imidazole and Triazole Derivatives / Imidazole Derivatives |
| Levoketoconazole | 531.431 C26H28Cl2N4O4 |  | One of two enantiomeric forms of racemic ketoconazole that strongly inhibits multiple steroidogenic enzymes and is used for the symptomatic treatment of endogenous Cushing's syndrome. | Anticorticosteroids |
Displaying drugs 2351 - 2375 of 2785 in total